Advertisement
Advertisement
OLMA
Olema Pharmaceuticals, Inc. Common Stock
32.58
USD-1.70
-4.96%
Dec 17, 15:59 UTC -5
Closed
After-Market
32.50
-0.08
-0.24%
Olema Pharmaceuticals, Inc. Common Stock Profile
About
Info & Links
CEO
Sean Bohen
Headquarters
San Francisco, CA 94103, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
67
Employees
96
Olema Pharmaceuticals, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
2.61B
Enterprise Value
2.57B
Enterprise Value/EBITDA(ttm)
-15.60
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
7.38
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-41.56%
Return on Invested Capital(ttm)
-42.30%
Return on Assets(ttm)
-37.65%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-164.96M
Net Income Available to Common(ttm)
-149.96M
Diluted EPS(ttm)
-1.87
Share Statistics
Beta (5Y Monthly)
1.85
52-Week Change
405.89%
S&P 500 52-Week Change
14.46%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
68.66M
Dividend Yield
0.00%
Float4
57.43M
% Held by Insiders
16.36%
% Held by Institutions
91.78%
Balance Sheet
Total Cash(mrq)
328.96M
Total Cash Per Share(mrq)
4.79
Total Debt(mrq)
3.00M
Total Debt/Equity(mrq)
0.98%
Current Ratio(mrq)
8.03%
Quick Ratio(mrq)
8.03%
Book Value Per Share(mrq)
4.48
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.26
Free Cash Flow(ytd)
-108.39M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement